SIRPA and ovarian carcinoma: Huang et al. reported that the oncolytic adenovirus carrying the SIRPα-IgG1 Fc fusion gene could block CD47 signaling in ovarian cancer cells, therefore, increasing macrophage infiltration and killing ovarian cancer cells [8].